Your browser doesn't support javascript.
loading
Male urinary paracetamol and semen quality.
Smarr, M M; Kannan, K; Chen, Z; Kim, S; Buck Louis, G M.
Affiliation
  • Smarr MM; Office of the Director, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Kannan K; Wadsworth Center, New York State Department of Health, Albany, NY, USA.
  • Chen Z; Department of Environmental Health Sciences, School of Public Health, State University of New York at Albany, Albany, NY, USA.
  • Kim S; Biostatistics and Bioinformatics Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Buck Louis GM; Biostatistics Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute, Bethesda, MD, USA.
Andrology ; 5(6): 1082-1088, 2017 Nov.
Article in En | MEDLINE | ID: mdl-28853221
ABSTRACT
The endocrine-disrupting properties of paracetamol have been previously demonstrated in rodent studies of abnormal sperm morphology and diminished testosterone production, in addition to epidemiologic studies of diminished couple fecundity. In this study, we examined the relationship between paracetamol and its metabolite p-aminophenol quantified in a single spot urine and semen quality among 501 male partners of couples planning for pregnancy. Men provided a urine specimen and two fresh semen samples collected approximately one month apart and underwent 24-h analysis for 35 semen quality parameters. Paracetamol and p-aminophenol were quantified in urine by ultra-high-performance liquid chromatography coupled with an electrospray triple quadrupole mass spectrometry. The relationship between natural-log-transformed urinary paracetamol and p-aminophenol rescaled by their standard deviation and 21 Box-Cox-transformed, 14 non-transformed semen parameters was assessed using linear mixed-effects models. The median concentrations (IQR) of urinary paracetamol and p-aminophenol were 15.5 ng/mL (5.44, 73.5) and 978 ng/mL (500, 1596), respectively. Following adjustment for creatinine and age, a 1-standard deviation increase in log-transformed urinary paracetamol was associated with a reduction in beat cross-frequency and an increase in DNA fragmentation [ß (95% CI) -0.59 Hz (-1.16, -0.03) and 0.05% (0.01, 0.09), respectively]. These findings were corroborated in models of categorical chemical concentrations; higher concentrations of paracetamol remained associated with reduced beat cross-frequency and increased DNA fragmentation. A 1-standard deviation increase in log-transformed urinary p-aminophenol was associated with a reduction in sperm head area [ß (95% CI) -0.1 µm2 (-0.18, -0.02) and width -0.02 µm (-0.04, -0.01)]. However, only the association with sperm head area remained statistically significant in models of p-aminophenol quartiles. Our findings suggest that adult male urinary paracetamol is associated with sperm motility and DNA fragmentation, while the metabolite, p-aminophenol, is predominantly associated with sperm head morphometry.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sperm Head / Sperm Motility / DNA Fragmentation / Acetaminophen Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Andrology Year: 2017 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sperm Head / Sperm Motility / DNA Fragmentation / Acetaminophen Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Andrology Year: 2017 Document type: Article Affiliation country: United States